Use of recombinant human erythropoietin in combination with parenteral iron in the treatment of postpartum anaemia

European Journal of Clinical Investigation

Volumn 26, Issue 2, 1996, Pages 123-130

  Breymann, C ^a   Zimmermann, R ^a   Huch, R ^a   Huch, A ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Endogenous erythropoietin; Erythropoiesis; Ferrokinetics; Postpartum anaemia; Recombinant human erythropoietin; Reticulocyte flow cytometry

Indexed keywords

ERYTHROPOIETIN; IRON; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FLOW CYTOMETRY; GOOD CLINICAL PRACTICE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PUERPERIUM; RANDOMIZED CONTROLLED TRIAL; RETICULOCYTE COUNT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030062787     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1996.109261.x     Document Type: Article

References (52)

1. Combs C, Murphy E, Laros R. Factors associated with postpartum hemorrhage with vaginal birth. Obstet Gynecol 1991;72:69-76.
2. Gilbert L, Porter W, Brown V. Postpartum haemorrhage a continuing problem. Br J Obst Gynecol 1987;94:67-71.
3. Naef R, Chauhan S, Chevalier S, Roberts W, Meydrech E, Morrison J. Prediction of hemorrhage at Cesarean delivery. Obstet Gynecol 1994;83:923-6.
4. Gillon J, Greenburg A. Transfusion: infectious complications. Blood 1992;54:19-28.
5. Morrison J, Floyd R, Martin R, Dodson M, Roberts W, Morrison F. Blood transfusions after postpartum hemorrhage due to uterine atony. J Matern Fetal Invest 1991;1:209-12.
6. Crosby L, Palarski V, Cottington E, Cmolik B. Iron supplementation for acute blood loss anaemia after coronary bypass surgery: a randomised placebo-controlled study. Heart-Lung 1994;23:493-9.
7. Schindler E, Scholz S, Boldt J, Zickmann B, Knothe C, Dietrich G. Effectiveness of oral versus parenteral iron substitution in autologous blood donors. Infusionsther-Transfusionsmed 1994;21:236-41.
8. Skikne B, Cook J. Effect of enhanced erythropoiesis on iron absorption. J Lab Clin Med 1992;120:746-51.
9. Suh H, Wadhawa N. Iron dextran treatment in peritoneal dialysis patients on erythropoietin. Adv Perit Dial 1992;8:464-6.
10. Erslev A. Anemia of chronic disease. In: Beutler E, Lichtman M, Coller B, Kipps T, eds. Williams Hematology. New York: McGraw Hill, 1995: 518-24.
11. Fischer C, Gill C, Forrester M, Nakamura R. Quantitation of 'acute-phase proteins' postoperatively. Am J Clin Pathol 1976;66:840-6.
12. Romem Y, Artal R. C-reactive protein in pregnancy and in the postpartum period. Am J Obstet Gynecol 1985;151:380-3.
13. Bornmann BV, Weiler J, Aulich S. Acute treatment with recombinant erythropoietin in patients with pre- and postoperative anaemia: a clinical report. Clin Invest 1994;72:S31-S35.
14. Dudrick S, O'Donnell J, Matheny R, Unkel S, Raleigh D. Stimulation of hematopoiesis as an alternative to transfusion. South Med J 1986;79:669-73.
15. Fullerton D, Campbell D, Whitman G. Use of human recombinant erythropoietin to correct severe preoperative anemia. Ann Thorac Surg 1991;51:823-4.
16. Goodnough L, Rudnick S, Price T et al. Increased preoperative collection of autologous blood with recombinant human erythropoietin Therapy. N Engl J Med 1989;321:1163-8.
17. Koenig H, Levine E, Resnick D, Meyer W. Use of recombinant human erythropoietin in a Jehovah's Witness. J Clin Anesth 1993;5:244-7.
18. Koestner J, Nelson L, Morris J, Safcsak K. Use of recombinant human erythropoietin (r-HuEPO) in a Jehovah's Witness refusing transfusion of blood products: case report. Trauma 1990;30:1406-8.
19. Levine E, Gould S, Rosen A, et al. Perioperative recombinant human erythropoietin. Surgery 1989;106:432-7.
20. Levine E, Rosen A, Gould S et al. Recombinant human erythropoietin and autologous blood donation. Surgery 1988;104:365-9.
21. Jelkmann W. Erythropoietin: structure, control of production, and function. Physiol Rev 1992;72:449-89.
22. Macdougall I, Cavill I, Hulme B, Bain B, Gregor EM, Kay PM. Detection of functional iron deficiency during erythropoietin treatment: a new approach. Br Med J 1992;304:225-6.
23. Macdougall I, Hutton R, Cavill I, Coles G, Williams J. Poor response to treatment of renal anaemia with erythropoietin corrected by iron given intravenously. Br Med J 1989;299:157-8.
24. Van Wyck DB. Iron management during recombinant erythropoietin therapy. Am J Kidney Dis 1989;14 (suppl 1):9-13.
25. Danko J, Huch R, Huch A. Epoetin alfa for treatment of postpartum anaemia. Lancet 1990;1:737-8.
26. Spivak J. The clinical physiology of erythropoietin. Semin Hemalol 1993;30:2-11.
27. Zimmermann R, Breymann C, Huch R, Huch A. rHuEPO in the treatment of postpartum anaemia: subcutaneous versus intravenous administralion. Clin Invest 1994;72:S25-S30.
28. Major A, Bauer C, Breymann C, Huch R, Huch A. rh-Erythropoietin stimulates immature reticulocyte release in man. Br J Haematol 1994;87:605-8.
29. Tanke H, Nieuwenhuis I, Koper G, Slats J, Ploem J. Flow cytometry of human reticulocytes based on RNA fluorescence. Cytometry 1980;1:313-20.
30. Tanke H, Rothbarth P, Vossen J, Koper G, Ploem J. Flow cytometry of reticulocytes applied to clinical hematology. Blood 1983; 61:1091 -7.
31. Tsuda I, Tatsumi N. Maturity of reticulocytes in various hematological disorders. Eur J Haematol 1989;43:252-4.
32. Eckardt K, Kurtz A, Hirth P, Scigalla P, Wieczorek L, Bauer C. Evaluation of the stability of human erythropoietin in samples for radioimmunoassay. Klinische Wochenschrift 1988;66:241-5.
33. Huebers H, Finch C. Transferrin: physiological behavior and clinical implications. Blood 1984;64:763-7.
34. Rose E, Abels R, Nelson R, Cullough DM, Lessin L. The use of rHuEPO in the treatment of anaemia related to myelodysplasia (MDS). Br J Haematol 1995;89:831-7.
35. Faquin W, Schneider T, Goldberg M. Effect of inflammatory cytokines on hypoxia induced erythropoietin production. Blood 1992;79:1987-94.
36. Huch A, Eichhorn K, Danko J, Lauener P, Huch R. Recombinant human erythropoietin (rHuEPO) in the treatment of post partum anemia. Obstet Gynecol 1992;80:127-31.
37. Adamson J. Iron and Erythropoiesis. New York: Marcel Dekker., 1993;161-76.
38. Hillman R. Acute blood loss anaemia. In: Beutler E, Lichtman M, Coller B, Kipps T, eds. Williams Hematology. New York: McGraw Hill, 1995: 704-8.
39. Biesma D, Wiel A, Beguin Y, Kraaijenhagen R, Marx J. Erythropoietic activity and iron metabolism in autologous blood donors during recombinant human erythropoietin therapy. Eur J Clin Invest 1994;24:426-32.
40. Goodnough L, Price T, Rudnick S. Iron-restricted erythropoiesis as a limitation to autologous blood donation in the erythropoietin-stimulated bone marrow. J Lab Clin Med 1991;118:289-96.
41. Hamstra R, Block M, Schocket A. Intravenous iron dextran in clinical medicine. JAMA 1980;243:1726-31.
42. Jacobs P, Finch C. Iron for erythropoiesis. Blood 1971;37:220-30.
43. Fairbanks V, Beutler E. Iron metabolism. In: Beutler E, Lichtman M, Coller B, Kipps T, eds. Williams Hematology. New York: McGraw Hill, 1995: 369-80.
44. Henderson A, Hillman R. Characteristics of iron dextran utilization in man. Blood 1969;34:357-75.
45. Jacobs P. Clinical use of total-dose infusion of iron dextran. S Afr Med J 1985;67:837-8.
46. Kindler J, Eckardt K, Ehmer B et al. Single-dose pharmacokinetics of recombinant human erythropoietin in patients with various degrees of renal failure. Nephrol Dial Transplant 1989;4:345-9.
47. Mahon FM, Vargas R, Ryan M, Jain A, Perry B, Smith I. Pharmacokinetics and effects of recombinant human erythropoietin after intravenous and suncutaneous injections in healthy volunteers. Blood 1990;9:1718-22.
48. Abraham P, Peter W, Kill K, Halstenson C. Controversies in determination of epoietin (recombinant human erythropoietin) dosages. Clin Pharmacokinet 1992;22:409-15.
49. Ashai N, Paganini E, Wilson J. Intravenous versus subcutaneous dosing of epoietin: a review of the literature. Am J Kidney Dis 1993;22:23-31.
50. Barclay P, Fischer E, Harris D. Interpatient variation in response to subcutaneous versus intravenous low dose erythropoietin. Clin Nephrol 1993;40:277-80.
51. Fairbanks V, Beutler E. Iron deficiency. In: Beutler E, Lichtman M, Coller B, Kipps T, eds. Williams Hematology. New York: McGraw Hill, 1995: 490-511.
52. Morrison J, Morrison F. Rational use of blood products in obstetrics and gynecology. J Matern Fetal Invest 1994;4:147-53.